Terms: = Germ cell tumor AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
175 results:
1. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
[TBL] [Abstract] [Full Text] [Related]
2. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
[TBL] [Abstract] [Full Text] [Related]
3. Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
Padonou F; Vanhulst T; Langouo-Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):63-68. PubMed ID: 38441065
[TBL] [Abstract] [Full Text] [Related]
4. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
Roy A; Chakraborty AR; DePamphilis ML
Mol Oncol; 2024 Apr; 18(4):988-1011. PubMed ID: 38414326
[TBL] [Abstract] [Full Text] [Related]
5. Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma.
Zhao H; Zhao Y; Zhang S; Wang Z; Yu W; Dong N; Yang X; Zhang X; Sun Q; Hao X; Ren X
Front Immunol; 2024; 15():1302751. PubMed ID: 38384466
[TBL] [Abstract] [Full Text] [Related]
6. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
7. Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant fus interaction under hyperosmotic stress.
Wang H; Zheng Y; Yu J; Meng L; Zhang W; Hong D; Wang Z; Yuan Y; Deng J
Neurobiol Dis; 2024 Jan; 190():106391. PubMed ID: 38145851
[TBL] [Abstract] [Full Text] [Related]
8. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
Chen KT; Huang CY; Pai PC; Yang WC; Tseng CK; Tsai HC; Li JC; Chuang CC; Hsu PW; Lee CC; Toh CH; Liu HL; Wei KC
J Neurooncol; 2023 Dec; 165(3):535-545. PubMed ID: 38060066
[TBL] [Abstract] [Full Text] [Related]
9. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.
Martinez PJ; Green AL; Borden MA
J Control Release; 2024 Jan; 365():412-421. PubMed ID: 38000663
[TBL] [Abstract] [Full Text] [Related]
10. Focused ultrasound for brain metastases: an update on global clinical trials.
Chen YH; Moore D; Lee CC; Su YH
J Neurooncol; 2023 Oct; 165(1):53-62. PubMed ID: 37910281
[TBL] [Abstract] [Full Text] [Related]
11. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
[TBL] [Abstract] [Full Text] [Related]
12. Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.
Zhan Y; Song Y; Qiao W; Sun L; Wang X; Yi B; Yang X; Ji L; Su P; Zhao W; Liu Z; Ren W
Br J Cancer; 2023 Oct; 129(7):1083-1094. PubMed ID: 37580442
[TBL] [Abstract] [Full Text] [Related]
13. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
[TBL] [Abstract] [Full Text] [Related]
14. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
[TBL] [Abstract] [Full Text] [Related]
15. Shikonin Causes Non-apoptotic cell Death in B16F10 Melanoma.
Ahmad H; Crotts MS; Jacobs JC; Baer RW; Cox JL
Anticancer Agents Med Chem; 2023; 23(16):1880-1887. PubMed ID: 37393553
[TBL] [Abstract] [Full Text] [Related]
16. Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.
Sah VR; Jespersen H; Karlsson J; Nilsson LM; Bergqvist M; Johansson I; Carneiro A; Helgadottir H; Levin M; Ullenhag G; Ståhlberg A; Olofsson Bagge R; Nilsson JA; Ny L
Cancer Res Commun; 2023 May; 3(5):884-895. PubMed ID: 37377898
[TBL] [Abstract] [Full Text] [Related]
17. Non-viral nitric oxide-based gene therapy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma models.
Bellary A; Nowak C; Iwanicki I; Flores-Guzman F; Wu L; Kandel JJ; Laetsch TW; Bleris L; Hernandez SL; Sirsi SR
Theranostics; 2023; 13(10):3402-3418. PubMed ID: 37351172
[TBL] [Abstract] [Full Text] [Related]
18. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.
Sorbi C; Belluti S; Atene CG; Marocchi F; Linciano P; Roy N; Paradiso E; Casarini L; Ronsisvalle S; Zanocco-Marani T; Brasili L; Lanfrancone L; Imbriano C; Di Rocco G; Franchini S
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298633
[TBL] [Abstract] [Full Text] [Related]
19. Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model.
't Hart E; Bianco J; Bruin MAC; Derieppe M; Besse HC; Berkhout K; Chin Joe Kie LA; Su Y; Hoving EW; Huitema ADR; Ries MG; van Vuurden DG
J Control Release; 2023 May; 357():287-298. PubMed ID: 37019285
[TBL] [Abstract] [Full Text] [Related]
20. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment.
Cybulska-Stopa B; Piejko K; Ostaszewski K; Dziura R; Galus Ł; Ziółkowska B; Kempa-Kamińska N; Ziętek M; Bal W; Kamycka A; Dudzisz-Śledź M; Kubiatowski T; Kamińska-Winciorek G; Suwiński R; Mackiewicz J; Czarnecka AM; Rutkowski P
Melanoma Res; 2023 Jun; 33(3):208-217. PubMed ID: 37015054
[TBL] [Abstract] [Full Text] [Related]
[Next]
